Similar Efficacy from Specific and Non-Specific Mineralocorticoid Receptor Antagonist Treatment of Muscular Dystrophy Mice-Reference-Cited by-同舟云学术

Similar Efficacy from Specific and Non-Specific Mineralocorticoid Receptor Antagonist Treatment of Muscular Dystrophy Mice

Published:2016-08-30 Issue:3 Volume:3 Page:395-404
ISSN:2214-3599
Container-title:Journal of Neuromuscular Diseases
language:
Short-container-title:JND

Author:

Lowe Jeovanna¹,Floyd Kyle T.¹,Rastogi Neha¹,Schultz Eric J.¹,Chadwick Jessica A.¹,Swager Sarah A.¹,Zins Jonathan G.¹,Kadakia Feni K.¹,Smart Suzanne²,Gomez-Sanchez Elise P.³,Gomez-Sanchez Celso E.⁴,Raman Subha V.²,Janssen Paul M.L.¹,Rafael-Fortney Jill A.¹

Affiliation:

1. Department of Physiology & Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA

2. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University, Columbus, OH, USA

3. Department of Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson, MS, USA

4. Department of Internal Medicine, University of Mississippi Medical Center, Jackson, MS, USA

Publisher

IOS Press

Subject

Clinical Neurology,Neurology

Reference22 articles.

1. The Pathogenesis and Therapy of Muscular Dystrophies;Guiraud;Annu Rev Genomics Hum Genet,2015

2. Diagnosis and management of Duchenne muscular dystrophy, part Diagnosis, and pharmacological and psychosocial management;Bushby;Lancet Neurol,2010

3. VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects;Heier;EMBO Molecular Medicine.,2013

4. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy;Janssen;PLoS One,2014

5. Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse;Sali;PLoS One,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-type specific effects of mineralocorticoid receptor gene expression suggest intercellular communication regulating fibrosis in skeletal muscle disease;Frontiers in Physiology;2024-04-26

2. Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model;Molecular Therapy - Methods & Clinical Development;2023-03

3. Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy;JCI Insight;2022-10-10

4. Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury;Frontiers in Pharmacology;2022-06-28

5. Myeloid mineralocorticoid receptors contribute to skeletal muscle repair in muscular dystrophy and acute muscle injury;American Journal of Physiology-Cell Physiology;2022-03-01